title: [Chemotherapy of osteoarticular tuberculosis].
abstract: Bone and joint tuberculosis, as all other types of tuberculosis is generally treated with antituberculotic combination chemotherapy. This has to be continued for a minimum of six months, or nine months in case of extensive spreading. A two- to three-month initial phase with four or five different drugs (H, R, Z, and additionally E and/or S) is followed by a four- to six-month therapy with H and R alone, provided the pathogen is fully susceptible to a standard regimen. The main side effects are hepatotoxic or allergic reactions. A frequent contra-indication is existing, often toxicity-induced, liver damage. The main local complications requiring surgery are spinal instability or neurologic deficiencies.
authors.affiliation: Lungenklinik Heckeshorn, Berlin.
authors.forename: M
authors.initials: M
authors.lastname: Serke
authors.forename: B
authors.initials: B
authors.lastname: Hauer
authors.forename: R
authors.initials: R
authors.lastname: Loddenkemper
mesh_terms: D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D014394:Tuberculosis, Osteoarticular / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents